Literature DB >> 25498760

A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides.

Anita Hartog1, Fabiën N Belle2, Jacqueline Bastiaans3, Priscilla de Graaff2, Johan Garssen3, Lucien F Harthoorn2, Arjan P Vos3.   

Abstract

Inflammatory bowel diseases (IBD) including ulcerative colitis (UC) and Crohn's disease (CD) are chronic relapsing inflammatory disorders of the gastrointestinal tract. The interaction between a disturbed microbial composition, the intestinal mucosal barrier and the mucosal immune system plays an important role in IBD and its chronicity. It has been indicated that due to the altered microbial composition the balance between T regulatory cells (Treg) and T helper cells (Th) 17 is disturbed, leading to an inflammatory state. The present study shows that oral intake of a specific multi fibre mix (MF), designed to match the fibre content of a healthy diet, counteracts IBD-like intestinal inflammation and weight loss in dextran sodium sulphate treated mice. This reduction in inflammation might be brought about, at least in part, by the MF-induced decrease in inflammatory cytokines, increase in IL-10 and the relative increase in Treg cells in the mesenteric lymph nodes (MLN). Moreover, the Treg percentage in the MLN correlates with the percentage of tolerogenic lamina propria derived CD103+RALDH+dendritic cells in the MLN, suggesting that these play a role in the observed effects. In children with CD exclusive enteral nutrition (EEN) is a widely used safe and effective therapy. Optimizing enteral nutritional concepts with the tested fibre mix, know to modulate the gut microbiota composition, SCFA production and inflammatory status (as indicated by the present study) could possibly further improve efficacy in inducing remission.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD103; IBD; Multifibre; Prebiotic; RALDH; Treg

Mesh:

Substances:

Year:  2014        PMID: 25498760     DOI: 10.1016/j.jnutbio.2014.10.011

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  22 in total

Review 1.  Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome.

Authors:  Larissa S Celiberto; Franziska A Graef; Genelle R Healey; Else S Bosman; Kevan Jacobson; Laura M Sly; Bruce A Vallance
Journal:  Immunology       Date:  2018-05-16       Impact factor: 7.397

2.  Protective Effects of Mekabu Aqueous Solution Fermented by Lactobacillus plantarum Sanriku-SU7 on Human Enterocyte-Like HT-29-luc Cells and DSS-Induced Murine IBD Model.

Authors:  Maki Nemoto; Takashi Kuda; Mika Eda; Hiroshi Yamakawa; Hajime Takahashi; Bon Kimura
Journal:  Probiotics Antimicrob Proteins       Date:  2017-03       Impact factor: 4.609

3.  Local level of TGF-β1 determines the effectiveness of dexamethasone through regulating the balance of Treg/Th17 cells in TNBS-induced mouse colitis.

Authors:  Peng You; Ning Chen; Lin Su; Tao Peng; Guodong Chen; Yulan Liu
Journal:  Exp Ther Med       Date:  2018-02-08       Impact factor: 2.447

4.  Anti-Adhesion Effects of Lactobacillus Strains on Caco-2 Cells Against Escherichia Coli and Their Application in Ameliorating the Symptoms of Dextran Sulfate Sodium-Induced Colitis in Mice.

Authors:  Tao Wang; Huimin Sun; Jiaxin Chen; Lingli Luo; Yaxin Gu; Xin Wang; Yuanyuan Shan; Yanglei Yi; Bianfang Liu; Yuan Zhou; Xin Lü
Journal:  Probiotics Antimicrob Proteins       Date:  2021-04-14       Impact factor: 4.609

Review 5.  Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer.

Authors:  Elena Talero; Sofía García-Mauriño; Javier Ávila-Román; Azahara Rodríguez-Luna; Antonio Alcaide; Virginia Motilva
Journal:  Mar Drugs       Date:  2015-09-30       Impact factor: 5.118

6.  Impacts of resistant starch and wheat bran consumption on enteric inflammation in relation to colonic bacterial community structures and short-chain fatty acid concentrations in mice.

Authors:  Richard R E Uwiera; G Douglas Inglis; Janelle A Jiminez; Trina C Uwiera; D Wade Abbott
Journal:  Gut Pathog       Date:  2016-12-22       Impact factor: 4.181

Review 7.  Effects of Non-Starch Polysaccharides on Inflammatory Bowel Disease.

Authors:  Ying Nie; Qinlu Lin; Feijun Luo
Journal:  Int J Mol Sci       Date:  2017-06-27       Impact factor: 5.923

Review 8.  Potential Impact of Diet on Treatment Effect from Anti-TNF Drugs in Inflammatory Bowel Disease.

Authors:  Vibeke Andersen; Axel Kornerup Hansen; Berit Lilienthal Heitmann
Journal:  Nutrients       Date:  2017-03-15       Impact factor: 5.717

Review 9.  Bugging inflammation: role of the gut microbiota.

Authors:  Sj Shen; Connie Hy Wong
Journal:  Clin Transl Immunology       Date:  2016-04-15

10.  Fibre intake and the development of inflammatory bowel disease: A European prospective multi-centre cohort study (EPIC-IBD).

Authors:  Vibeke Andersen; Simon Chan; Robert Luben; Kay-Tee Khaw; Anja Olsen; Anne Tjonneland; R Kaaks; Olof Grip; M M Bergmann; H Boeing; Johan Hultdin; Pontus Karling; Kim Overvad; Bas Oldenburg; Jorrit Opstelten; Marie-Christine Boutron-Ruault; Franck Carbonnel; Antoine Racine; Timothy Key; Giovanna Masala; Domenico Palli; R Tumino; A Trichopoulou; Elio Riboli; Andrew Hart
Journal:  J Crohns Colitis       Date:  2018-01-24       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.